SCHEMBL328464

SCHEMBL328464

Cc1nc2cccc(CNC(=O)c3ccc(CF)cc3)c2c(=O)n1C1CCC(=O)NC1=O

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 11/20 0.56
DDB1 Q16531 10/20 0.56
TNF P01375 1/20 0.56
IL1B P01584 1/20 0.56
IKZF3 Q9UKT9 1/20 0.56
CSNK1A1 P48729 1/20 0.49
IKZF1 Q13422 1/20 0.49
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
BRD4 O60885 3/20 0.36
NAMPT P43490 1/20 0.36
THRB P10828 1/20 0.36
HDAC8 Q9BY41 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL282665 0.92 CRBN (0.59) CRBNDDB1TNFIL1BIKZF3
SCHEMBL283159 0.91 CRBN (0.60) CRBNDDB1TNFIL1BIKZF3
SCHEMBL282990 0.90 CRBN (0.56) CRBNDDB1TNFIL1BIKZF3
SCHEMBL282762 0.90 CRBN (0.58) CRBNDDB1TNFIL1BIKZF3
SCHEMBL328502 0.90 CRBN (0.58) CRBNDDB1TNFIL1BIKZF3
SCHEMBL283343 0.88 CRBN (0.54) CRBNDDB1TNFIL1BIKZF3
SCHEMBL283366 0.88 CRBN (0.53) CRBNDDB1TNFIL1BIKZF3
SCHEMBL18509457 0.88 CRBN (0.53) CRBNDDB1TNFIL1BIKZF3
SCHEMBL282617 0.87 CRBN (0.56) CRBNDDB1TNFIL1BIKZF3
SCHEMBL24113869 0.87 CRBN (0.58) CRBNDDB1TNFIL1BIKZF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428513-A1 5-substituted quinazolinone derivatives as anti-cancer agents Celgene Corporation (US) 2012-03-14 EP disclosed
EP-2420498-A1 5-substituted quinazolinone derivatives as anti-cancer agents Celgene Corporation (US) 2012-02-22 EP disclosed
EP-2420497-A1 5-substituted quinazolinone derivatives as anti-cancer agents CELGENE CORPORATION (US) 2012-02-22 EP disclosed
WO-2008039489-A2 5-SUBSTITUTED QUINAZOLINONE DERIVATIVES AS ANTITUMOR AGENTS CELGENE CORPORATION (US) 2008-04-03 WO disclosed